Skip to main content
Premium Trial:

Request an Annual Quote

Eli Lilly Licenses Inpharmatica's Admensa Interactive

NEW YORK (GenomeWeb News) - Eli Lilly has licensed Inpharmatica's Admensa Interactive software platform, Inpharmatica said today.
 
Admensa Interactive is a suite of predictive models and decision tools for drug discovery.
 
Financial details were not disclosed.

Filed under

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.